A significant amount of misses and major reporting mistakes occur when radiologists increase imaging reporting speeds, according to results of a study published online May 21 in the Journal of the American College of Radiology.

It seems we are starting to see the debate over appropriate supplemental screening for breast cancer with a little more focus and a clearer picture of who would benefit most, thanks to some interesting new research.

Siemens’ PETNET Solutions has entered into an agreement with U.K.-based Blue Earth Diagnostics to secure exclusive commercial manufacturing and distribution of fluciclovine (18F), an investigational PET radiopharmaceutical, once the agent receives FDA approval.

VeriTeQ Corporation ("VeriTeQ" or the "Company") (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has been awarded a U.S. Patent for Wireless Molecular Sensor System and Process. The Company intends to utilize the patent in the development of future bio-sensing microchip applications, initially focused on its radiation dose measurement technologies used during cancer treatment. 

Shimadzu Medical Systems USA is pleased to announce the first U.S. west coast installation of its Trinias C-12 high performance “crossover” system at Kalispell Regional Medical Center in Kalispell, MT. Shimadzu dealer/partner Core Medical Imaging, Inc. of Kenmore, WA completed the first west coast installation of the Trinias angiographic system which went into operation at the medical center in late April.

Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque (iodixanol) than those using low-osmolar contrast media (LOCM), demonstrate data from abstracts presented today at the EuroPCR Congress 2015 in Paris. 

Breast density notification laws have taken hold in 22 states and counting, yet questions remain about which patient should receive supplemental cancer screening. A newly published study this week has shed some light on the issue, showing that not all women with dense breast are at high risk for breast cancer.

Recommended cancer screenings have been shown to increase early diagnosis and save lives in at-risk patient populations. A government initiative called Healthy People 2020 includes targets for increasing screening levels for breast and colorectal cancer over the next five years to improve cancer survival and overall public health, but progress updates are necessary to ensure that such targets are within reach.